The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-sec-butyl-3-oxo-2,3-dihydroimidazo[1,2-c]quinazolin-5-ylthio)-N-o-tolylbutanamide ID: ALA4212457
Cas Number: 1052659-30-9
PubChem CID: 20965633
Max Phase: Preclinical
Molecular Formula: C25H28N4O2S
Molecular Weight: 448.59
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCC(SC1=Nc2ccccc2C2=NC(C(C)CC)C(=O)N12)C(=O)Nc1ccccc1C
Standard InChI: InChI=1S/C25H28N4O2S/c1-5-15(3)21-24(31)29-22(28-21)17-12-8-10-14-19(17)27-25(29)32-20(6-2)23(30)26-18-13-9-7-11-16(18)4/h7-15,20-21H,5-6H2,1-4H3,(H,26,30)
Standard InChI Key: HTFJGDBBWXQQCN-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
2.8055 -12.0364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8055 -12.8557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5155 -13.2674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5155 -11.6288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2256 -12.0364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2256 -12.8557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6457 -12.0364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9356 -11.6288 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3516 -11.6288 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.3516 -10.8096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6457 -10.3979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9356 -10.8096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0617 -10.3979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0617 -9.5786 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6457 -12.8557 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9356 -13.2674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1051 -14.0688 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9199 -14.1540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2514 -13.4052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0529 -13.2357 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3275 -14.8640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9199 -15.5741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1467 -14.8640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5584 -14.1540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7697 -10.8058 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7694 -9.1700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4727 -9.5815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1799 -9.1736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1803 -8.3555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4676 -7.9471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7633 -8.3573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4701 -10.3987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 8 1 0
6 16 1 0
15 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
10 13 1 0
13 14 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 15 1 0
19 20 2 0
18 21 1 0
21 22 1 0
21 23 1 0
23 24 1 0
13 25 2 0
14 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
27 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 448.59Molecular Weight (Monoisotopic): 448.1933AlogP: 5.15#Rotatable Bonds: 6Polar Surface Area: 74.13Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.13CX Basic pKa: 1.98CX LogP: 6.31CX LogD: 6.31Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.66Np Likeness Score: -0.96
References 1. Yang SM, Martinez NJ, Yasgar A, Danchik C, Johansson C, Wang Y, Baljinnyam B, Wang AQ, Xu X, Shah P, Cheff D, Wang XS, Roth J, Lal-Nag M, Dunford JE, Oppermann U, Vasiliou V, Simeonov A, Jadhav A, Maloney DJ.. (2018) Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity., 61 (11): [PMID:29767973 ] [10.1021/acs.jmedchem.8b00270 ] 2. Li B, Yang K, Liang D, Jiang C, Ma Z.. (2021) Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors., 209 [PMID:33328099 ] [10.1016/j.ejmech.2020.112940 ]